<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=1200, user-scalable=yes, initial-scale=0.4, minimum-scale=0.1">
    <title>Phenazepam - Complete Profile</title>
    <link rel="stylesheet" href="/Dyo-s-Dubious-Domain/style.css">
    <link rel="icon" type="image/svg+xml" href="/Dyo-s-Dubious-Domain/assets/logo.svg">
    <script>
        // Set base path for JavaScript files to use
        window.SITE_BASE_PATH = '/Dyo-s-Dubious-Domain/';
        
        // Force desktop behavior by overriding mobile detection
        window.isMobile = false;
        window.isDesktop = true;
        
        // Override any mobile detection functions
        if (window.matchMedia) {
            const originalMatchMedia = window.matchMedia;
            window.matchMedia = function(query) {
                // Force desktop media queries to always match for min-width
                // and mobile queries to never match
                if (query.includes('max-width') && (query.includes('768px') || query.includes('480px'))) {
                    return { matches: false, addListener: function() {}, removeListener: function() {} };
                }
                if (query.includes('min-width')) {
                    return { matches: true, addListener: function() {}, removeListener: function() {} };
                }
                return originalMatchMedia.call(this, query);
            };
        }
    </script>
</head>

<body class="
  
  
  
  ">
    <header class="page-header">
  <div class="container">
    <div class="page-header__content">
      <div class="logo-container">
        <a href="/Dyo-s-Dubious-Domain/" class="site-title">Dyo's Dubious Domain</a>
      </div>
      
      <nav>
        <ul role="list" class="nav-list flex-group">
          <li>
            <a href="/Dyo-s-Dubious-Domain/">Home</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/dyos-domain/">Dyo's Domain</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/about/">About</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/profile/">My Profile</a>
          </li>
         
        </ul>
      </nav>
    </div>
    
    <!-- Search Bar - Now underneath header -->
    <div class="search-container">
      <input type="text" id="search-input" placeholder="Search substances..." class="search-input" />
      <div id="search-results" class="search-results" style="display: none;"></div>
    </div>
  </div>
</header>

    <main>
      
<div class="substance-profile-header">
  <div class="container">
    <nav class="breadcrumb">
      <a href="/dyos-domain/">Dyo's Domain</a> ‚ÜÅE<a href="/dyos-domain/depressants/">Depressants</a> ‚ÜÅE<span>Phenazepam</span>
    </nav>
    
    <div class="substance-hero">
      <div class="substance-info">
        <h1>üí§ Phenazepam</h1>
        <h2 class="chemical-name">7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one</h2>
        
        <!-- Add to Profile Button -->
        <button id="add-to-profile-btn" class="add-to-profile-btn not-in-profile" 
                data-substance="Phenazepam" 
                data-category="Depressant" 
                data-chemical="7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one">
          + Add to My Profile
        </button>
        
        <div class="alternative-names">
          <h3>Alternative Names & Slang</h3>
          <div class="names-grid">
            <span class="name-item">Phenazepam</span>
            <span class="name-item">Fenazepam</span>
            <span class="name-item">Phenzepam</span>
            <span class="name-item">7-Bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one</span>
            <span class="name-item">Russian Benzos</span>
            <span class="name-item">Soviet Xanax</span>
            <span class="name-item">–§e–Ωa–∑e–øa–º (Cyrillic)</span>
            <span class="name-item">Designer Benzos</span>
            <span class="name-item">RC Benzos</span>
            <span class="name-item">Legal Benzos</span>
            <span class="name-item">Gray Market Benzos</span>
            <span class="name-item">Clearnet Benzos</span>
          </div>
        </div>
        
        <div class="substance-meta-large">
          <span class="category depressant">Depressant</span>
          <span class="legal-status unscheduled">Unscheduled</span>
          <span class="duration extremely-long">12-24+ hours</span>
        </div>
      </div>
      
      <div class="substance-visual">
        <div class="substance-image">
          <img src="/Dyo-s-Dubious-Domain/assets/substances/phenazepam.jpg" alt="Phenazepam tablets and powder" class="substance-photo">
        </div>
        <div class="molecule-structure">
          <div class="structure-placeholder">
            <p>C‚ÇÅ‚ÇÖH‚ÇÅÔøΩEBrClN‚ÇÇO</p>
            <p>Halogenated benzodiazepine</p>
          </div>
        </div>
      </div>
    </div>
  </div>
</div>

<div class="container">
  
  <div class="profile-grid">
    
    <div class="profile-section identification">
      <h3>üîç Physical Identification</h3>
      <div class="identification-info">
        <div class="pure-form">
          <h4>Pure Phenazepam</h4>
          <ul>
            <li><strong>Appearance:</strong> White or off-white crystalline powder</li>
            <li><strong>Solubility:</strong> Poorly soluble in water, soluble in alcohol</li>
            <li><strong>Taste:</strong> Bitter, metallic taste</li>
            <li><strong>Melting point:</strong> 213-216¬∞C</li>
            <li><strong>Activity:</strong> Active in sub-milligram doses</li>
          </ul>
        </div>
        
        <div class="street-forms">
          <h4>Commercial Forms</h4>
          <ul>
            <li><strong>Tablets:</strong> Usually 0.5mg, 1mg, or 2.5mg pressed pills</li>
            <li><strong>Powder:</strong> Bulk powder (extremely dangerous)</li>
            <li><strong>Pellets:</strong> Research chemical pellets</li>
            <li><strong>Solutions:</strong> Propylene glycol or ethanol solutions</li>
          </ul>
        </div>
        
        <div class="adulterants-warning">
          <h4>‚ö†ÔøΩEÔøΩEDosing Dangers</h4>
          <p><strong>Powder form:</strong> Impossible to dose accurately without analytical scale</p>
          <p><strong>Fake tablets:</strong> May contain fentanyl or other dangerous substances</p>
          <p><strong>Mislabeled potency:</strong> Street tablets often contain unknown amounts</p>
          <p><strong>Cross-contamination:</strong> Scales used for other drugs can cause overdose</p>
        </div>
      </div>
    </div>
    
    <div class="profile-section dosage">
      <h3>üíä Dosage Guidelines</h3>
      <div class="dosage-chart">
        <div class="dose-range threshold">
          <span class="range-label">Threshold</span>
          <span class="dose-amount">0.25-0.5mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range light">
          <span class="range-label">Light</span>
          <span class="dose-amount">0.5-1mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range common">
          <span class="range-label">Common</span>
          <span class="dose-amount">1-2mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range strong">
          <span class="range-label">Strong</span>
          <span class="dose-amount">2-3mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range heavy">
          <span class="range-label">Heavy</span>
          <span class="dose-amount">3mg+</span>
          <div class="dose-bar"></div>
        </div>
      </div>
      
      <div class="dosage-details">
        <h4>Critical Dosage Information</h4>
        <ul>
          <li><strong>Onset:</strong> 1-3 hours (very delayed, leading to redosing)</li>
          <li><strong>Duration:</strong> 12-24+ hours (exceptionally long)</li>
          <li><strong>Potency:</strong> 5-10x more potent than diazepam</li>
          <li><strong>Blackout threshold:</strong> As low as 2-3mg</li>
          <li><strong>Redosing danger:</strong> Delayed onset causes accidental overdose</li>
          <li><strong>Tolerance:</strong> Develops rapidly with daily use</li>
        </ul>
      </div>
      
      <p class="dosage-note"><strong>EXTREME WARNING:</strong> Phenazepam has caused numerous hospitalizations and deaths due to its delayed onset, extreme potency, and exceptionally long duration. Many users redose believing it's not working, leading to multi-day blackouts.</p>
    </div>

    <div class="profile-section effects">
      <h3>‚ú® Effects Profile</h3>
      
      <div class="effects-timeline">
        <h4>Timeline</h4>
        <div class="timeline-item">
          <span class="time">T+1:00-3:00</span>
          <span class="effect">Onset - delayed, subtle anxiety relief</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+3:00-8:00</span>
          <span class="effect">Peak - profound sedation, amnesia</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+8:00-24:00</span>
          <span class="effect">Plateau - continued impairment</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+24:00-72:00</span>
          <span class="effect">Comedown - gradual return to baseline</span>
        </div>
      </div>

      <div class="effects-categories">
        <div class="effect-category positive">
          <h4>‚úÅEPositive Effects</h4>
          <ul>
            <li>Powerful anxiety relief</li>
            <li>Muscle relaxation</li>
            <li>Sleep induction</li>
            <li>Anticonvulsant properties</li>
            <li>Amnesia (can be therapeutic)</li>
            <li>Sedation</li>
          </ul>
        </div>
        
        <div class="effect-category negative">
          <h4>‚ùÅENegative Effects</h4>
          <ul>
            <li>Complete memory blackouts</li>
            <li>Extreme sedation</li>
            <li>Respiratory depression</li>
            <li>Loss of coordination</li>
            <li>Dangerous disinhibition</li>
            <li>Multi-day impairment</li>
            <li>Compulsive redosing</li>
            <li>Severe withdrawal</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section pharmacology">
      <h3>üß† Pharmacology & Neuroscience</h3>
      <div class="pharma-details">
        <h4>Primary Mechanism of Action</h4>
        <p>Phenazepam is a classical benzodiazepine that acts as a positive allosteric modulator of GABA-A receptors. It binds to the benzodiazepine binding site on GABA-A receptors, enhancing the inhibitory effects of GABA. The presence of both bromine and chlorine substituents increases its potency and duration compared to classic benzodiazepines.</p>
        
        <h4>Receptor Pharmacology</h4>
        <div class="receptor-table">
          <div class="receptor-row">
            <span class="receptor">GABA-A</span>
            <span class="action">Positive allosteric modulator</span>
            <span class="effect">Enhanced inhibition, sedation</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">Œ±1 subunit</span>
            <span class="action">High affinity binding</span>
            <span class="effect">Sedation, amnesia</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">Œ±2/Œ±3 subunits</span>
            <span class="action">Moderate affinity</span>
            <span class="effect">Anxiolysis, muscle relaxation</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">Œ±5 subunit</span>
            <span class="action">Significant binding</span>
            <span class="effect">Memory impairment, amnesia</span>
          </div>
        </div>

        <h4>Pharmacokinetics</h4>
        <div class="metabolism-details">
          <p><strong>Absorption:</strong> Slow and variable oral absorption</p>
          <p><strong>Onset:</strong> 1-3 hours (dangerously delayed)</p>
          <p><strong>Peak plasma:</strong> 3-6 hours after oral dose</p>
          <p><strong>Half-life:</strong> 60+ hours (extremely long)</p>
          <p><strong>Duration:</strong> 12-24+ hours of noticeable effects</p>
          <p><strong>Metabolism:</strong> Hepatic via CYP3A4, slow clearance</p>
          <p><strong>Active metabolites:</strong> Several long-acting metabolites</p>
        </div>

        <h4>Unique Pharmacological Properties</h4>
        <div class="neurotoxicity-info">
          <p><strong>Extreme potency:</strong> 5-10x more potent than diazepam by weight</p>
          <p><strong>Exceptionally long duration:</strong> Effects can persist for multiple days</p>
          <p><strong>High amnesic potential:</strong> Profound memory impairment at therapeutic doses</p>
          <p><strong>Delayed onset:</strong> Creates high risk for accidental overdose</p>
          <p><strong>Poor water solubility:</strong> Makes solution preparation dangerous</p>
        </div>

        <h4>Neurochemical Effects</h4>
        <ul>
          <li><strong>GABA enhancement:</strong> Dramatic increase in inhibitory neurotransmission</li>
          <li><strong>Dopamine suppression:</strong> Reduced dopaminergic activity in reward pathways</li>
          <li><strong>Memory consolidation:</strong> Severe disruption of memory formation</li>
          <li><strong>Motor control:</strong> Significant impairment of coordination and balance</li>
          <li><strong>Cognitive function:</strong> Marked reduction in attention and decision-making</li>
        </ul>
      </div>
    </div>

    <div class="profile-section safety">
      <h3>‚ö†ÔøΩEÔøΩESafety & Harm Reduction</h3>
      
      <div class="safety-grid">
        <div class="safety-item critical">
          <h4>üö® Critical Warnings</h4>
          <ul>
            <li><strong>Delayed onset:</strong> Wait 4+ hours before considering redosing</li>
            <li><strong>Multi-day blackouts:</strong> Users report losing 2-3 days of memory</li>
            <li><strong>Respiratory depression:</strong> Dangerous when combined with other depressants</li>
            <li><strong>Compulsive redosing:</strong> Leads to severe overdose</li>
            <li><strong>Withdrawal seizures:</strong> Can be life-threatening</li>
          </ul>
        </div>
        
        <div class="safety-item precautions">
          <h4>üõ°ÔøΩEÔøΩEPrecautions</h4>
          <ul>
            <li>Use analytical scale for dosing (0.1mg precision minimum)</li>
            <li>Have sober trip sitter for entire duration</li>
            <li>Remove access to more doses after taking initial amount</li>
            <li>Never drive or operate machinery for 48+ hours</li>
            <li>Avoid all alcohol and other depressants</li>
            <li>Plan for 2-3 day recovery period</li>
            <li>Start with lowest possible dose (0.25mg)</li>
          </ul>
        </div>
      </div>

      <div class="contraindications">
        <h4>üö´ Contraindications</h4>
        <p><strong>Do not use if you have:</strong> Respiratory problems, sleep apnea, liver disease, history of substance abuse, depression, or are taking any other depressants. Not suitable for recreational use due to extreme impairment.</p>
      </div>
    </div>

    <div class="profile-section interactions">
      <h3>‚öóÔ∏ÅEDrug Interactions</h3>
      
      <div class="interaction-levels">
        <div class="interaction dangerous">
          <h4>üî¥ Extremely Dangerous</h4>
          <ul>
            <li><strong>Alcohol:</strong> Fatal respiratory depression</li>
            <li><strong>Opioids:</strong> Severe respiratory depression, death</li>
            <li><strong>Other benzodiazepines:</strong> Additive CNS depression</li>
            <li><strong>Barbiturates:</strong> Potentially fatal interaction</li>
            <li><strong>GHB/GBL:</strong> Dangerous sedation, coma risk</li>
          </ul>
        </div>
        
        <div class="interaction risky">
          <h4>üü° High Risk</h4>
          <ul>
            <li><strong>Antihistamines:</strong> Increased sedation and confusion</li>
            <li><strong>Sleep medications:</strong> Dangerous over-sedation</li>
            <li><strong>Antipsychotics:</strong> Enhanced CNS depression</li>
            <li><strong>Muscle relaxants:</strong> Increased impairment</li>
          </ul>
        </div>
        
        <div class="interaction caution">
          <h4>üü† Use Extreme Caution</h4>
          <ul>
            <li><strong>Cannabis:</strong> Increased sedation and memory loss</li>
            <li><strong>Anticonvulsants:</strong> Altered seizure threshold</li>
            <li><strong>Antidepressants:</strong> Possible interaction with metabolism</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section legal">
      <h3>‚öñÔ∏ÅELegal Status</h3>
      <div class="legal-info">
        <div class="legal-jurisdictions">
          <div class="jurisdiction">
            <strong>United States:</strong> Unscheduled federally, some states have banned it
          </div>
          <div class="jurisdiction">
            <strong>United Kingdom:</strong> Class C controlled substance since 2012
          </div>
          <div class="jurisdiction">
            <strong>European Union:</strong> Controlled in most member states
          </div>
          <div class="jurisdiction">
            <strong>Russia:</strong> Prescription medication, controlled substance
          </div>
          <div class="jurisdiction">
            <strong>Australia:</strong> Schedule 4 prescription medicine
          </div>
        </div>
        
        <div class="therapeutic-status">
          <h4>üè• Medical Status</h4>
          <p>Phenazepam was developed in the Soviet Union in the 1970s and is still prescribed in Russia and some former Soviet states for anxiety, insomnia, and epilepsy. However, its extreme potency and duration make it problematic for clinical use compared to modern benzodiazepines.</p>
        </div>
      </div>
    </div>

    <div class="profile-section history">
      <h3>üìö History & Culture</h3>
      
      <div class="history-timeline">
        <div class="history-event">
          <span class="year">1975</span>
          <p>Developed by the All-Union Research Institute of Pharmaceutical Chemistry in Moscow</p>
        </div>
        <div class="history-event">
          <span class="year">1978</span>
          <p>Introduced to Soviet medical practice for anxiety and epilepsy treatment</p>
        </div>
        <div class="history-event">
          <span class="year">2007</span>
          <p>First appears in Western research chemical markets</p>
        </div>
        <div class="history-event">
          <span class="year">2009-2012</span>
          <p>Multiple overdoses and deaths reported across Europe and US</p>
        </div>
        <div class="history-event">
          <span class="year">2012</span>
          <p>UK classifies as Class C controlled substance</p>
        </div>
        <div class="history-event">
          <span class="year">2010s</span>
          <p>Various jurisdictions ban or control the substance</p>
        </div>
      </div>

      <div class="cultural-impact">
        <h4>Cultural Impact</h4>
        <p>Phenazepam became notorious in the research chemical community for causing numerous hospitalizations and "horror stories" involving multi-day blackouts. Its reputation as an extremely dangerous substance led to widespread warnings in harm reduction communities and contributed to increased regulation of novel benzodiazepines.</p>
      </div>
    </div>

    <div class="profile-section research">
      <h3>üî¨ Current Research</h3>
      
      <div class="research-areas">
        <div class="research-item">
          <h4>Overdose Case Studies</h4>
          <p>Medical literature documenting the dangerous effects of phenazepam, including case reports of severe intoxication and the challenges of treating overdoses.</p>
        </div>
        
        <div class="research-item">
          <h4>Pharmacokinetic Studies</h4>
          <p>Research into the metabolism and elimination of phenazepam to better understand its exceptionally long duration and delayed onset.</p>
        </div>
        
        <div class="research-item">
          <h4>Analytical Detection</h4>
          <p>Development of better methods for detecting phenazepam in biological samples for forensic and clinical purposes.</p>
        </div>
        
        <div class="research-item">
          <h4>Regulatory Science</h4>
          <p>Studies examining the public health impact of novel benzodiazepines and informing regulatory decisions.</p>
        </div>
      </div>
    </div>

  </div>

  <div class="substance-resources">
    <h3>üìñ Additional Resources</h3>
    <div class="resources-grid">
      <div class="resource-item">
        <h4>Emergency Information</h4>
        <ul>
          <li><a href="https://www.poisoncontrol.org/">Poison Control Center</a> - Emergency guidance</li>
          <li><a href="https://www.samhsa.gov/">SAMHSA</a> - Crisis and treatment resources</li>
          <li><a href="https://www.ncbi.nlm.nih.gov/">PubMed</a> - Medical literature on phenazepam</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Harm Reduction</h4>
        <ul>
          <li><a href="https://www.erowid.org/chemicals/phenazepam/">Erowid Phenazepam Vault</a> - Experience reports and information</li>
          <li><a href="https://psychonautwiki.org/wiki/Phenazepam">PsychonautWiki</a> - Comprehensive drug information</li>
          <li><a href="https://www.bluelight.org/">Bluelight</a> - Drug discussion forum</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Support & Treatment</h4>
        <ul>
          <li><a href="https://www.reddit.com/r/benzorecovery/">r/BenzoRecovery</a> - Support community</li>
          <li><a href="https://www.samhsa.gov/find-help/national-helpline">SAMHSA National Helpline</a> - Treatment referral</li>
          <li><a href="https://www.benzoinfo.com/">Benzodiazepine Information Coalition</a> - Education and advocacy</li>
        </ul>
      </div>
    </div>
  </div>

</div>


    </main>
     <div class="footer-divider"></div>
<footer class="site-footer">
  
</footer>




<footer class="site-footer">
  
  </svg>
    <img src="/Dyo-s-Dubious-Domain/assets/logo.svg" alt="My Logo" class="logo">
     <p>¬© 2025 Uwaniumnya. Highly Illegal.</p>
  </footer>

  

    <!-- Search Scripts -->
    <script src="/Dyo-s-Dubious-Domain/js/lunr.min.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/search.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/substance-integration.js"></script>
    
    <!-- Only load profile.js on profile page -->
    
    
    <!-- Only load interaction-checker.js on interaction checker page -->
    
</body>
</html>